Stay updated on Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.

Latest updates to the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page footer revision/version label is updated from **v3.5.2** to **v3.5.3**, indicating a platform release rather than a change to the ClinicalTrials.gov study information.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page was updated from version v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check87 days agoChange DetectedA new site revision tag v3.4.2 was added, and older notices including a lapse-of-funding notice and the previous revision v3.4.1 were removed, with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center status was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.